HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Corpus cavernosum-corpus spongiosum shunt plus intracavernous tunneling for the treatment of prolonged ischemic priapism].

AbstractOBJECTIVE:
To investigate the efficacy and safety of corpus cavernosum-corpus spongiosum shunt (CC-CSS) plus intracavernous tunneling(CC-CSS+ICT) for the treatment of prolonged ischemic priapism (PIP) were investigated.
METHODS:
Of 21 patients with PIP, 11 (Group A) underwent CC-CSS and 10 (Group B) CC-CSS+ICT surgery. The penile hardness score (PHS) and pain visual analogue score (PVAS) were used to assess the efficacy of the surgery.
RESULTS:
The erectile functions of the two groups were normal (IIEF5 23.6+/-1.1) before the onset of PIP, and the duration of PIP was (3.4+/-1.3) d. PHS 3.9+/-0.4, and PVAS 8.4+/-0.7. There was no statistical difference between the two groups (P>0.05). On 1, 3 and 5 days after the operation, the PHS and PVAS of Group B decreased significantly than those of Group A (P<0.05).
CONCLUSION:
CC-CSS+ICT could quickly restore penile detumescence and relieve pain as compared with CC-CSS, which might be a safe and effective method for the treatment of PIP.
AuthorsWen-qing Lian, Wan-shou Cui, Zhe Jin, Jian Zhang, Tao Liu, Wei-ren Li, Yi-ming Yuan, Zhong-cheng Xin
JournalBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences (Beijing Da Xue Xue Bao Yi Xue Ban) Vol. 42 Issue 4 Pg. 421-4 (Aug 18 2010) ISSN: 1671-167X [Print] China
PMID20721256 (Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Arteriovenous Shunt, Surgical (instrumentation, methods)
  • Erectile Dysfunction (surgery)
  • Humans
  • Ischemia (surgery)
  • Male
  • Middle Aged
  • Penis (blood supply, surgery)
  • Priapism (physiopathology, surgery)
  • Treatment Outcome
  • Urologic Surgical Procedures, Male (instrumentation, methods)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: